Valuation: Microba Life Sciences Limited

Market Cap 37.82M 26.97M 23.36M 22.09M 20M 37.53M 2.59B 264M 101M 1.31B 101M 99.06M 4.18B P/E 2027 *
-6x
P/E 2028 * -27x
Enterprise Value 30.4M 21.68M 18.78M 17.76M 16.08M 30.17M 2.08B 212M 81.52M 1.05B 81.43M 79.62M 3.36B EV / Sales 2027 *
1.55x
EV / Sales 2028 * 0.97x
Free-Float
63.14%
Yield 2027 *
-
Yield 2028 * -
1 day-1.85%
1 week-5.36%
Current month-1.85%
1 month-1.85%
3 months+23.26%
6 months-33.75%
Current year-30.26%
1 week 0.05
Extreme 0.051
0.05
1 month 0.05
Extreme 0.049
0.06
Current year 0.04
Extreme 0.036
0.1
1 year 0.04
Extreme 0.036
0.1
3 years 0.04
Extreme 0.036
0.37
5 years 0.04
Extreme 0.036
0.45
10 years 0.04
Extreme 0.036
0.45
Manager TitleAgeSince
Chief Executive Officer - 01/07/2021
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 01/01/2024
Director TitleAgeSince
Director/Board Member - 31/01/2017
Director/Board Member - -
Chairman - -
Date Insider Type Main position Quantity % Market Cap. Importance
11/19/24 A Buy

Chairman

100,000 0.0223%
11/19/24 A Buy

Chairman

100,000 0.0223%
11/19/24 A Buy

Director

200,000 0.0447%
Change 5-day change 1-year change 3-year change Capi.($)
-1.85%-5.36%-39.08%-85.28% 26.97M
+2.63%+8.22%+103.75%+581.13% 50.56B
+2.75%-0.27%+17.64%+60.66% 26.27B
+0.98%+0.21%-13.04%-36.97% 6.82B
+2.16%+7.16%+2.84%+170.50% 6.07B
-0.75%-1.23%+15.96%+60.58% 3.32B
+5.46%+10.21%-22.45%+2,060.73% 2.82B
+2.61%+7.57%+133.79%+40.34% 2.43B
-0.56%+2.41%+36.67%+45.45% 2.25B
-2.11%+1.47%-16.12%-55.03% 1.83B
Average +1.15%+2.47%+22.00%+284.21% 10.24B
Weighted average by Cap. +2.34%+2.71%+58.63%+369.87%

Financials

2027 *2028 *
Net sales 19.67M 14.03M 12.15M 11.49M 10.4M 19.52M 1.35B 137M 52.75M 682M 52.69M 51.52M 2.18B 31.1M 22.18M 19.21M 18.17M 16.45M 30.87M 2.13B 217M 83.41M 1.08B 83.32M 81.47M 3.44B
Net income -6.8M -4.85M -4.2M -3.97M -3.6M -6.75M -465M -47.4M -18.24M -236M -18.22M -17.81M -752M -1.8M -1.28M -1.11M -1.05M -952K -1.79M -123M -12.55M -4.83M -62.44M -4.82M -4.72M -199M
Net Debt -7.42M -5.29M -4.58M -4.33M -3.92M -7.36M -508M -51.72M -19.9M -257M -19.88M -19.43M -821M -7.56M -5.39M -4.67M -4.42M -4M -7.5M -517M -52.7M -20.28M -262M -20.25M -19.8M -836M
Logo Microba Life Sciences Limited
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel.
Employees
-
Date Price Change Volume
16/09/26 A$0.0530 -1.85% 133,600
14/09/26 A$0.0540 -3.57% 68,172
09/09/26 A$0.0560 -1.75% 240
08/09/26 A$0.0570 +2.70% 30,231
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0540AUD
Average target price
0.1182AUD
Spread / Average Target
+118.93%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!